BRIBF Stock BRII BIOSCIENCE (BRIBF, $0.24) was a top winner yesterday, jumping +4.07%

GET DAILY SIGNALS

Get AI intraday signals

BRIBF - BRII BIOSCIENCE LTD

Loading...

Price: $0.2406

Daily change: +$0.0094 (+4.07%)

Daily volume: 2.4K

Capitalization: $173.2M

Industry: Biotechnology

BRII BIOSCIENCE (BRIBF, $0.24) was one of the top gainers yesterday, rising to $0.24 per share. A.I.dvisor analyzed 809 stocks in the Biotechnology Industry and found that of them (4) are in an Uptrend while of them (5) are in a Downtrend.

BRIBF sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for BRIBF moved below the 200-day moving average on November 14, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Technical Analysis (Indicators)

Bearish Trend Analysis

Bullish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BRIBF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.496) is normal, around the industry mean (23.122). P/E Ratio (0.000) is within average values for comparable stocks, (61.014). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.073). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (1111.111) is also within normal values, averaging (332.704).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRIBF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.